Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05501938
Other study ID # 6456
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 11, 2022
Est. completion date August 11, 2023

Study information

Verified date August 2022
Source Albany Medical College
Contact Craig Zelig, MD
Phone 9105464305
Email zeligc@amc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

RCT assessing preterm delivery rate in singleton pregnancies having a physical-exam indicated cerclage placed between 24 weeks and 25 weeks and 6 days. Patients randomized to either cerclage intervention or routine standard of care (no cerclage).


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date August 11, 2023
Est. primary completion date August 11, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Pregnant women 18 years of age or older 2. Nulliparous patient, has not had a preterm to term delivery 3. Singleton pregnancy 4. English or Spanish speaking 5. Asymptomatic cervical dilation between 1- 2 cm, without visible membranes beyond the external cervical os and without any evidence of infection, active labor or active bleeding between 24 0/7 and 25 6/7 weeks gestation Exclusion Criteria: 1. Twin or higher order multi-fetal gestation 2. Multiparous patient, has had one or more preterm to term deliveries 3. Cervical dilation more than 2 cm either at the beginning of the study or any time during the study 4. Amniotic membranes prolapsed beyond the external os 5. Fetal reduction procedure performed during current pregnancy 6. Ruptured membranes prior to randomization 7. Major fetal structural anomaly 8. Fetal chromosomal abnormality, suspected or confirmed with additional genetic testing 9. Cerclage already in place for other indication 10. Active vaginal bleeding 11. Suspicion of chorioamnionitis 12. Placenta previa 13. Painful regular uterine contractions 14. History of preterm birth before 37 weeks gestation 15. Non-English or non-Spanish speaking a. Given that the study is explained in person and consent forms are written in English, there is no guarantee that the study will be explained correctly when using a phone translator. The same is true if the current English consent form were to be translated into a language other than English. There is no way to confirm that the integrity of the study is being upheld by using translating services. If the integrity of the study is not upheld, then this poses harm to the patient. 16. Women under 18 years of age

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Physical Exam Indicated Cerclage
Transvaginal cervical cerclage

Locations

Country Name City State
United States Albany Medical Center Albany New York

Sponsors (1)

Lead Sponsor Collaborator
Albany Medical College

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Cerclage Surgical Complications Rate of cerclage complications (intra-operative PPROM, hemorrhage, need for blood transfusion, cervical or vaginal laceration 1 year
Primary Preterm Delivery Rate Compare preterm delivery rate between women receiving cerclage intervention between 24w0d and 25w6d vs those not receiving cerclage during this gestational age period 1 Year
Secondary Neonatal Outcomes Rate of neonatal outcomes compared between the two groups ( NICU length of stay, neonatal death, neonatal disease (bronchopulmonary dysplasia, Necrotizing enterocolitis, Intraventricular hemorrhage, Respiratory distress syndrome, Retinopathy of prematurity, sepsis, death) 1 Year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Completed NCT02993744 - Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone N/A
Active, not recruiting NCT02673216 - Infection and Adverse Pregnancy Outcome
Completed NCT01683565 - Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood Phase 4
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT01412931 - Protein and Ultrasound Indicators of Preterm Birth N/A
Completed NCT02606058 - The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? N/A
Terminated NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women N/A
Completed NCT00422526 - Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial Phase 3
Enrolling by invitation NCT04251260 - Effectiveness of Positioning in Preterm Neonates N/A
Completed NCT03668860 - India Dexamethasone and Betamethasone Phase 1
Recruiting NCT03638037 - Correlation Between Maternal Vitamin D Level And Preterm Birth
Completed NCT02225353 - Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Phase 2
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT03144141 - Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery N/A
Completed NCT05210985 - Examination of the Relationship Between Home Affordances With Development
Completed NCT04021654 - What is the Future of Vulnerable New-borns